Comparison of inhaled and intravenous terbutaline in acute severe asthma.
In patients with acute severe asthma, 5 mg of terbutaline by inhalation and 500 microgram intravenously in divided doses both produced equally effective but not maximal bronchodilatation. There was no difference in the production of side-effects. These results support the view that inhaled therapy c...
Uloženo v:
| Vydáno v: | Thorax |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
1981
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC471658/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7031975/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.36.8.629 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|